Braakhuis BJ - Search Results

1

Preclinical in vivo activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human head and neck cancer.

Braakhuis BJ, van Dongen GA, Vermorken JB, Snow GB. Braakhuis BJ, et al. Cancer Res. 1991 Jan 1;51(1):211-4. Cancer Res. 1991. PMID: 1988086

2

Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984.

Schrijvers AH, Gerretsen M, van Walsum M, Braakhuis BJ, Quak JJ, Snow GB, van Dongen GA. Schrijvers AH, et al. Among authors: braakhuis bj. Cancer Immunol Immunother. 1992;34(4):252-8. doi: 10.1007/BF01741793. Cancer Immunol Immunother. 1992. PMID: 1371426 Free PMC article.

3

Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.

Gerretsen M, Schrijvers AH, van Walsum M, Braakhuis BJ, Quak JJ, Meijer CJ, Snow GB, van Dongen GA. Gerretsen M, et al. Among authors: braakhuis bj. Br J Cancer. 1992 Sep;66(3):496-502. doi: 10.1038/bjc.1992.302. Br J Cancer. 1992. PMID: 1520586 Free PMC article.

4

Carcinoembryonic antigen and head and neck cancer.

Laarman DA, van Kamp GJ, Balm AJ, Braakhuis BJ, Snow GB. Laarman DA, et al. Among authors: braakhuis bj. Clin Otolaryngol Allied Sci. 1991 Apr;16(2):182-6. doi: 10.1111/j.1365-2273.1991.tb01973.x. Clin Otolaryngol Allied Sci. 1991. PMID: 2070537 Clinical Trial.

5

Comparative study of the sensitivity of head and neck cell lines to methotrexate (MTX) and the analog 10-ethyl, 10-deazaaminopterin (10-EdAM).

Brown DH, Braakhuis BJ, Van Dongen GA, Snow GB. Brown DH, et al. Among authors: braakhuis bj. Otolaryngol Head Neck Surg. 1990 Jan;102(1):20-5. doi: 10.1177/019459989010200104. Otolaryngol Head Neck Surg. 1990. PMID: 2106113

6

Antitumor activity of brequinar sodium (Dup-785) against human head and neck squamous cell carcinoma xenografts.

Braakhuis BJ, van Dongen GA, Peters GJ, van Walsum M, Snow GB. Braakhuis BJ, et al. Cancer Lett. 1990 Feb;49(2):133-7. doi: 10.1016/0304-3835(90)90149-r. Cancer Lett. 1990. PMID: 2306706

7

Activity of differentiation-inducing agents and conventional drugs in head and neck cancer xenografts.

van Dongen G, Braakhuis BJ, Bagnay M, Leyva A, Snow GB. van Dongen G, et al. Among authors: braakhuis bj. Acta Otolaryngol. 1988 May-Jun;105(5-6):488-93. doi: 10.3109/00016488809119507. Acta Otolaryngol. 1988. PMID: 2456664

8

Anti-tumor and differentiation-inducing activity of N,N-dimethylformamide (DMF) in head-and-neck cancer xenografts.

van Dongen GA, Braakhuis BJ, Leyva A, Hendriks HR, Kipp BB, Bagnay M, Snow GB. van Dongen GA, et al. Among authors: braakhuis bj. Int J Cancer. 1989 Feb 15;43(2):285-92. doi: 10.1002/ijc.2910430221. Int J Cancer. 1989. PMID: 2465278

9

Preclinical antitumor activity of 5-aza-2'-deoxycytidine against human and neck cancer xenografts [corrected].

Braakhuis BJ, van Dongen GA, van Walsum M, Leyva A, Snow GB. Braakhuis BJ, et al. Invest New Drugs. 1988 Dec;6(4):299-304. doi: 10.1007/BF00173648. Invest New Drugs. 1988. PMID: 2466014

10

Preclinical chemotherapy on human head and neck cancer xenografts grown in athymic nude mice.

Braakhuis BJ, van Dongen GA, Bagnay M, van Walsum M, Snow GB. Braakhuis BJ, et al. Head Neck. 1989 Nov-Dec;11(6):511-5. doi: 10.1002/hed.2880110607. Head Neck. 1989. PMID: 2584006

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters